KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Evolent Health (EVH) Equity Income (2016 - 2026)

Evolent Health has reported Equity Income over the past 12 years, most recently at $65000.0 for Q4 2025.

  • For Q4 2025, Equity Income fell 59.12% year-over-year to $65000.0; the TTM value through Dec 2025 reached $446000.0, up 112.96%, while the annual FY2025 figure was $365000.0, 110.61% up from the prior year.
  • Equity Income for Q4 2025 was $65000.0 at Evolent Health, down from $200000.0 in the prior quarter.
  • Over five years, Equity Income peaked at $7.8 million in Q1 2021 and troughed at -$2.2 million in Q3 2024.
  • A 5-year average of $809050.0 and a median of $250000.0 in 2023 define the central range for Equity Income.
  • Biggest five-year swings in Equity Income: soared 2122.22% in 2022 and later plummeted 950.0% in 2024.
  • Year by year, Equity Income stood at $454000.0 in 2021, then surged by 45.37% to $660000.0 in 2022, then crashed by 95.76% to $28000.0 in 2023, then soared by 467.86% to $159000.0 in 2024, then plummeted by 59.12% to $65000.0 in 2025.
  • Business Quant data shows Equity Income for EVH at $65000.0 in Q4 2025, $200000.0 in Q3 2025, and $200000.0 in Q2 2025.